Anticoagulants Article Drug/Class Study design Sample size Follow-up (months) Withdrawal schedule Bertozzo 2016 Warfarin Prospective cohort 798 25 Not described Patel 2013 Rivaroxaban Post-hoc analysis of a non-inferiority RCT 5882 1 Not described